section name header

Basics

[Section Outline]

Author:

Daniel F.Leiva

TaranehMatin

AaronHexdall


Description!!navigator!!

Etiology!!navigator!!

Pregnancy Prophylaxis
HZV during pregnancy is not associated with maternal or obstetric morbidity

Pediatric Considerations
May occur in childhood, most commonly when primary varicella occurred in utero or in the first 6 mo of life

Diagnosis

[Section Outline]

Signs and Symptoms!!navigator!!

Essential Workup!!navigator!!

Diagnostic Tests & Interpretation!!navigator!!

Lab

  • VZV DNA PCR is the gold stand ard:
    • From vesicle scraping, blood, saliva, CSF, or BAL
    • Can distinguish between HSV and VZV
    • Most sensitive and specific
  • Tzanck smear:
    • Cheap and easy; scrape base of unroofed vesicle
    • Multinucleated giant cells with intranuclear inclusion seen on methylene blue, Giemsa, or Wright's stain
    • Modified technique can distinguish VZV from HSV
    • Low sensitivity
  • Serology antibody titers:
    • Helpful in CNS vasculopathy as PCR may be negative
    • Not sensitive nor specific
  • Viral culture:
    • 1-2 wk to result
    • Specific but not sensitive

Differential Diagnosis!!navigator!!

Treatment

[Section Outline]

Prehospital!!navigator!!

ED Treatment/Procedures!!navigator!!

Pregnancy Prophylaxis
  • Same treatment as immunocompetent patients
  • Vaccine contraindicated in pregnancy

Pediatric Considerations
Neonatal zoster requires treatment with IV acyclovir

Medication!!navigator!!

First Line

  • Oral antivirals:
    • Valacyclovir: 1 g PO q8h × 7 d
    • Acyclovir: 800 mg PO q4h × 7-10 d
  • IV antivirals:
    • Acyclovir: 10 mg/kg IV q8h × 7 days
  • Analgesics:
    • Acetaminophen: 500 mg PO q6h; not to exceed 4 g/d
    • Ibuprofen: 600 mg PO q6h
    • Oxycodone CR: 10 mg PO q12h
    • Amitriptyline: 25 mg PO q.h.s; increase as tolerated to 100 mg/d
    • Cyclopentolate ophthalmic 1%: Apply 1 gtt q8h to affected eye
  • Analgesia in PHN:
    • Lidocaine patch 5%: Apply up to 3 patches for a maximum of 12 hr within a 24-hr period
  • Prednisone:
    • 60 mg PO daily × 7 d followed by 30 mg daily × 7 d then 15 mg daily × 7 d
  • PEP:
    • Varicella zoster immunoglobulin (VariZIG): IM/IV 125 units/10 kg body weight up to maximum of 625 units
  • Vaccine:
    • Zostavax (Merck): One-time SC injection

Second Line

  • Antivirals for acyclovir-resistant immunocompromised patient:
    • Foscarnet: 90 mg/kg IV as 2-hr infusion every 12 hr (not FDA approved)
    • Cidofovir: 5 mg/kg weekly for 2 wk followed by 5 mg/kg every other week (not FDA approved)
  • Antibiotics:
    • Erythromycin ophthalmic ointment USP 0.5%: apply 1 in q4h to affected eye
  • Analgesics:
    • Gabapentin: 100-300 mg q8h or 300 mg q.h.s increasing 100-300 mg every 3 d until adequate response or max 3,600 mg/d
    • Pregabalin: 75 mg PO q12h or 75 mg q.h.s; increase 75 mg twice daily every 3 d as tolerated. Max 600 mg/d
    • Nortriptyline: 10-25 mg q.h.s; increase by 10-25 mg × 3-7 d as tolerated to max 150 mg/d

Follow-Up

Disposition

Admission Criteria

  • Immunocompromise including stem cell and organ transplant patients
  • Disseminated disease
  • HZO with cranial nerve involvement
  • Intractable pain
  • Isolation:
    • Airborne precautions for all patients with primary varicella or disseminated zoster, or immunocompromised patients with dermatomal zoster
    • Patients are infectious from 48 hr before appearance of rash until crusting of all lesions

Discharge Criteria

  • Most are managed as outpatients
  • Patients should be instructed that lesions may heal with scarring or leave depigmented areas
  • Recommend isolation from pregnant or immunocompromised persons until all lesions are crusted
  • PHN may require long-term follow-up and /or referral to pain specialist
Pregnancy Prophylaxis
Usually treated as outpatients

Pediatric Considerations
Admit all neonates with zoster

Pearls and Pitfalls

  • Look for ocular involvement if rash involves the tip of the nose (Hutchinson sign)
  • Expose the skin of every patient with chest pain
  • Failure to consider the diagnosis in the absence of rash
  • Failure to warn patients of the risk of PHN

Additional Reading

Codes

ICD9

ICD10

SNOMED